Bill Text: TX SB270 | 2017-2018 | 85th Legislature | Introduced


Bill Title: Relating to health benefit plan coverage for abuse-deterrent opioid analgesic drugs.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Introduced - Dead) 2017-01-30 - Referred to Business & Commerce [SB270 Detail]

Download: Texas-2017-SB270-Introduced.html
  85R3192 MEW-D
 
  By: Creighton S.B. No. 270
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to health benefit plan coverage for abuse-deterrent opioid
  analgesic drugs.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Chapter 1369, Insurance Code, is amended by
  adding Subchapter J to read as follows:
  SUBCHAPTER J. COVERAGE FOR ABUSE-DETERRENT OPIOID ANALGESIC DRUGS 
         Sec. 1369.451.  DEFINITIONS. In this subchapter:
               (1)  "Abuse-deterrent opioid analgesic drug" means an
  opioid analgesic drug that the United States Food and Drug
  Administration has approved and for which the United States Food
  and Drug Administration has approved abuse-deterrence labeling
  that indicates the drug is expected to result in a meaningful
  reduction in abuse. 
               (2)  "Opioid analgesic drug" means a drug in the opioid
  analgesic drug class that:
                     (A)  is prescribed to treat moderate to severe
  pain or other conditions; and
                     (B)  may be:
                           (i)  in an immediate-release or
  extended-release form of the drug;
                           (ii)  a single component drug; or
                           (iii)  in combination with another drug.
         Sec. 1369.452.  APPLICABILITY OF SUBCHAPTER. (a)  This
  subchapter applies only to a health benefit plan that provides
  benefits for medical or surgical expenses incurred as a result of a
  health condition, accident, or sickness, including an individual,
  group, blanket, or franchise insurance policy or insurance
  agreement, a group hospital service contract, or an individual or
  group evidence of coverage or similar coverage document that is
  offered by:
               (1)  an insurance company;
               (2)  a group hospital service corporation operating
  under Chapter 842;
               (3)  a fraternal benefit society operating under
  Chapter 885;
               (4)  a stipulated premium company operating under
  Chapter 884;
               (5)  a reciprocal exchange operating under Chapter 942;
               (6)  a health maintenance organization operating under
  Chapter 843;
               (7)  a multiple employer welfare arrangement that holds
  a certificate of authority under Chapter 846; or
               (8)  an approved nonprofit health corporation that
  holds a certificate of authority under Chapter 844.
         (b)  Notwithstanding Section 1501.251 or any other law, this
  subchapter applies to a small employer health benefit plan subject
  to Chapter 1501.
         (c)  Notwithstanding any other law, a standard health
  benefit plan provided under Chapter 1507 must provide the coverage
  required by this subchapter.
         Sec. 1369.453.  EXCEPTIONS. (a)  This subchapter does not
  apply to:
               (1)  a health benefit plan that provides coverage only:
                     (A)  for a specified disease or for another
  limited benefit other than for cancer;
                     (B)  for accidental death or dismemberment;
                     (C)  for wages or payments in lieu of wages for a
  period during which an employee is absent from work because of
  sickness or injury;
                     (D)  as a supplement to a liability insurance
  policy;
                     (E)  for credit insurance;
                     (F)  for dental or vision care; or
                     (G)  for indemnity for hospital confinement;
               (2)  a Medicare supplemental policy as defined by
  Section 1882(g)(1), Social Security Act (42 U.S.C. Section 1395ss);
               (3)  a workers' compensation insurance policy;
               (4)  medical payment insurance coverage provided under
  a motor vehicle insurance policy; or
               (5)  a long-term care insurance policy, including a
  nursing home fixed indemnity policy, unless the commissioner
  determines that the policy provides benefit coverage so
  comprehensive that the policy is a health benefit plan as described
  by Section 1369.452.
         (b)  This subchapter does not apply to:
               (1)  the Medicaid managed care program operated under
  Chapter 533, Government Code;
               (2)  the Medicaid program operated under Chapter 32,
  Human Resources Code; or
               (3)  the child health plan program operated under
  Chapter 62, Health and Safety Code.
         Sec. 1369.454.  REQUIRED COVERAGE FOR ABUSE-DETERRENT
  OPIOID ANALGESIC DRUGS. (a) A health benefit plan must provide
  coverage for abuse-deterrent opioid analgesic drugs.
         (b)  A health benefit plan issuer may not reduce or limit a
  payment to a health care professional, or otherwise penalize the
  professional, because the professional prescribes or dispenses an
  abuse-deterrent opioid analgesic drug.
         Sec. 1369.455.  PRIOR AUTHORIZATION. (a) A health benefit
  plan may require prior authorization for an abuse-deterrent opioid
  analgesic drug in the same manner that the health benefit plan
  requires prior authorization for an opioid analgesic drug that does
  not have abuse-deterrent properties.
         (b)  A health benefit plan may not require an enrollee to use
  an opioid analgesic drug that does not have abuse-deterrent
  properties before prior authorization for an abuse-deterrent
  opioid analgesic drug may be given.
         SECTION 2.  Subchapter J, Chapter 1369, Insurance Code, as
  added by this Act, applies only to a health benefit plan that is
  delivered, issued for delivery, or renewed on or after January 1,
  2018. A health benefit plan that is delivered, issued for delivery,
  or renewed before January 1, 2018, is covered by the law as it
  existed immediately before the effective date of this Act, and that
  law is continued in effect for that purpose.
         SECTION 3.  This Act takes effect September 1, 2017.
feedback